SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-138778
Filing Date
2020-12-23
Accepted
2020-12-22 21:54:12
Documents
2
Effectiveness Date
2020-12-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2039126d2_defa14a.htm DEFA14A 32639
2 GRAPHIC tm2039126d2_img001.jpg GRAPHIC 3468
  Complete submission text file 0001104659-20-138778.txt   38696
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36751 | Film No.: 201409616
SIC: 2836 Biological Products, (No Diagnostic Substances)